MaxCyte, Inc. (MXCT)
1.35
+0.04
(+3.05%)
USD |
NASDAQ |
Nov 06, 10:20
MaxCyte EPS Diluted (Quarterly) : -0.0831 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0831 |
| March 31, 2026 | -0.0444 |
| December 31, 2025 | -0.0899 |
| September 30, 2025 | -0.1165 |
| June 30, 2025 | -0.1161 |
| March 31, 2025 | -0.0968 |
| December 31, 2024 | -0.1004 |
| September 30, 2024 | -0.11 |
| June 30, 2024 | -0.0896 |
| March 31, 2024 | -0.0915 |
| December 31, 2023 | -0.0509 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.1088 |
| June 30, 2023 | -0.102 |
| March 31, 2023 | -0.1058 |
| December 31, 2022 | -0.0471 |
| September 30, 2022 | -0.0632 |
| June 30, 2022 | -0.0814 |
| March 31, 2022 | -0.0402 |
| December 31, 2021 | -0.0483 |
| September 30, 2021 | -0.0267 |
| June 30, 2021 | -0.0522 |
| March 31, 2021 | -0.0839 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 0.00 |
| Bruker Corp. | -0.8052 |
| Azenta, Inc. | 0.0542 |
| Danaher Corp. | 1.747 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.874M |
| Revenue (Quarterly) | 7.271M |
| Total Expenses (Quarterly) | 16.14M |
| Enterprise Value | 50.60M |
| Gross Profit Margin (Quarterly) | 63.86% |
| Profit Margin (Quarterly) | -122.0% |
| Earnings Yield | -24.73% |
| Normalized Earnings Yield | -20.08 |